Fattydaddy29
8時間前
Well, I’m the guy with the gut feeling, and I don’t knock anybody who stays in it. I’ve even said hey if this thing pops and I made a mistake then oh well. But it got me looking into other companies that are in this same industry, battery storage. And I found what appears to be a good company who reports real contracts that are completely verified. They’ve been around for 18 years and based right here In the USA. In fact, they’re starting up another plant in Pittsburgh Pennsylvania. Granted it’s not a pink sheet penny stock and I’m not buying 1 million shares, but I feel it’s real value And a solid company. This is just a real me talking no AI Assisted paragraphs.
Dnx_PH
16時間前
Building Value: The Reality of MBAK’s Momentum
It is a testament to the company’s progress that the opposition has nothing left but to rehash the same stale, repetitive complaints. Whether appearing on the public board or arriving directly in my inbox, these messages serve only to highlight the lack of substance behind the bearish stance. It is clear that some prefer to dwell on subjective "gut feelings" rather than confront the objective reality of the business. By ignoring the fundamental data, these individuals blind themselves to the very momentum they claim does not exist.
While they are busy cycling through emotional venting, the actual story of the company remains consistent and rooted in tangible action:
• Operational Momentum: The company continues the systematic execution of its $65 million order backlog. This fulfillment process is the primary driver of growth, providing the operational backbone that detractors conveniently choose to ignore.
• Financial Momentum: Strong revenue growth continued into Q1 2026, with the company reporting revenue and net income figures that reflect solid gross margins.
• Strategic Foundation: The company has actively expanded its capabilities, such as incorporating MBAK India Private Ltd., specifically designed to navigate regulatory frameworks and streamline the integration of its Battery Energy Storage Systems (BESS).
• Share Structure Discipline: The company maintains a stable share count, avoiding toxic dilution. The recent issuance of approximately 25 million shares appears strategically aimed at aligning high-caliber talent with the board and organization.
• Share Repurchase Program: Demonstrating confidence in its valuation, the Board of Directors has authorized a $500,000 share repurchase plan, funded directly from cash reserves and recent order fulfillment payments.
• Facility Expansion: Plans are underway to expand operations into a 40,000 sq. ft. U.S. manufacturing facility in Wilmington, NC, by September 2026.
• Recurring Revenue Floor: Recent earnings guidance highlighted a new specialized cell order delivering approximately $750,000 per month for one year, providing a consistent revenue stream expected to cover corporate overhead.
• Global Expansion: Documented growth in regions like Africa, India, and Europe serves as a concrete indicator of the firm's expanding international footprint, far removed from the speculative, subjective "gut feelings" pushed by those who have already exited their positions.
Market Trajectory and Outlook
The disconnect between the recycled hit pieces of the “critics” and the company’s actual trajectory is wider than ever. While others speculate on past price points or vent personal frustrations, my focus here remains on the execution of the $65 million backlog and the compounding value created by these operational milestones. As the company continues to hit its targets and expand its footprint, the underlying fundamentals are becoming increasingly difficult for the "usual suspects" to dismiss.
I am uninterested in the static of those who would rather complain than observe the construction of value. I am positioned to remain focused on the upside, tracking the company's progress as it translates this operational momentum into long-term growth. The math and the milestones speak for themselves; I am ignoring the noise and staying focused on the value being built.
OTC_Watchdog
2日前
The address Michelle Boos gave the federal court for MBAK does not exist.
In her own filing to the United States District Court, Michelle Boos listed the following address for herself and MBAK:
4120 US HWY 421 N, Building 4, Wilmington, NC 28401
On June 15, 2026, the court docketed two returned envelopes — Documents 47 and 48 — stamped by USPS: "RETURN TO SENDER — NO SUCH NUMBER — UNABLE TO FORWARD."
USPS confirmed the address does not exist.
This address is also different from every other address MBAK has filed in official documents:
— OTC Markets profile: 3940 US Highway 421 N, Wilmington, NC 28401
— Wyoming SOS 2026 Annual Report, certified by Boos under penalty of perjury: Wilmington Trade Center, Building 3, 3940 US Highway 421 N
Three filings. Three different addresses. Two different street numbers. Two different building numbers.
Two questions follow from this:
First: the address Boos gave the court is different from every other address she has filed elsewhere — and it does not exist. Did she provide a non-existent address to the federal court to avoid being contactable, and with that delay the legal proceedings against her?
Second: if the address she gave the court is wrong, are the addresses she certified to Wyoming SOS and OTC Markets also wrong? At this point, does MBAK have any verified, deliverable address at all?
A company and its management that cannot provide a consistent, accurate address across government filings, regulatory disclosures, and federal court submissions raises a straightforward question: what exactly are they hiding, and from whom?
Case record is public: PACER, Case No. 4:26-cv-00091-JDR-SH, N.D. Oklahoma.
OTC_Watchdog
2日前
Update — Case No. 4:26-cv-00091-JDR-SH, N.D. Oklahoma — June 15, 2026
Judge John D. Russell issued a Minute Order today granting Plaintiffs' motion to strike.
The Court ruled that Michelle Boos and Nolin Han — as unrepresented, pro se parties — cannot file requests for relief on behalf of corporate entities. The filings submitted by Boos and Han on behalf of MIA Global USA, Inc. and MBAK Energy Solutions, Inc. have been stricken from the record.
The Court's order states directly: "Defendants MIA Global USA, Inc. and MBAK Energy Solutions, Inc. must seek relief through counsel."
The corporate defendants now have no filings on the record, no legal representation, and passed response deadlines. Their only attempt to respond has been struck by the Court.
The judge has now told MBAK directly: get a lawyer.
Why won't they?
The door for a default motion is now wide open.
Drallision
2日前
You’re correct, plus the Q was never filed with OTC Markets, which makes them 30 days in default. Boos spoke about what she posted on her website. Fraud, hoax, lies. This is criminal, but then again, Boos is a lifelong SCAM ARTIST!
Dnx_PH
2日前
It’s almost impressive how the script never changes. We are watching an "expert-level" display of redundancy—the same claims, the same "concerns," and the same predictable attempts to generate fear, all while ignoring the actual progress happening on the ground. It is honestly exhausting that these critics continue to recycle these loaded questions, especially when management already provided a transparent, refreshing, and comprehensive breakdown during the recent earnings call—a level of clarity that is practically unheard of in the murky, bottom-feeding world of OTC micro-caps.
While the "detectives" are busy playing games in the comments, the company continues to execute. Let’s refocus on the verifiable data, not the theatrics.
The Financial and Operational Reality:
• Proven Revenue: The company reported $3.01 million in revenue and $1.40 million in net income for Q1 2026, maintaining solid gross margins of approximately 51%.
• Operational Integration: To address concerns regarding certification, the company incorporated a local subsidiary, MBAK India Private Ltd., specifically designed to navigate India's regulatory environment and streamline BESS integration for its $65 million order backlog.
• Strategic Growth: These efforts are bolstered by new partnerships in Zambia’s Copperbelt, proving that the company is actively expanding its footprint where it counts.
Market Outlook:
The broader market move I anticipated is now unfolding, providing the necessary tailwind for MBAK. This macro shift significantly increases the probability of achieving my established price targets as the market begins to align with the company’s underlying fundamentals. In my opinion, a quick move to 3 cents is even more possible, followed by a sustainable appreciation into the 8 to 10-cent range as the company’s real-world progress compounds. The math is certified, the execution is tangible, and the upside remains my primary focus. Let the critics continue to repeat their tired conspiracy theories.
OTC_Watchdog
3日前
A simple question for MBAK management.
MBAK has announced the following delivery commitments, all of which are past due or nearly so:
— October 27, 2025: Delivery of 100 MWh of BESS units to an Indian power grid customer by April 30, 2026 — now 46 days overdue
— March 18, 2026: Shipments to India and Zambia announced as already underway — 89 days ago
— April 29, 2026: "Confirmed on-time shipment" of eleven BESS units to India and Africa — 47 days ago, also exceeding the maximum 45-day door-to-door transit time
— April 29, 2026: "Beginning of delivery" of ESS systems to Kenyan coffee farmers — 47 days ago, no follow-up
— April 29, 2026: Additional 40 MWh to India to be delivered by June 2026 — 15 days remaining, no progress update
Standard sea freight from China to India or Zambia takes a maximum of 45 days door-to-door. The March 18 shipments — announced 89 days ago — should have arrived by early May at the latest. The April 29 shipments — 47 days ago — should have arrived by mid-June at the latest. Neither has been confirmed.
On the same day as the April 29 announcement, MBAK also claimed "confirmed on-time shipment" of eleven BESS units to India and Africa. Nineteen days later, on the May 18 earnings call, Chairman Boos stated that containers were still in China awaiting Indian customs paperwork and customer payment. Dr. Konda confirmed that Indian government certification required for delivery did not yet exist.
MBAK's own management contradicted their own press release on their own earnings call.
It is now June 15. No press release has confirmed that a single shipment has arrived at its destination. The OTC Markets news page has been silent since March 18 — the same day shipments were declared underway.
Has a single customer taken physical delivery of BESS units? Has a single customer payment been received?
The silence answers the question.
Dnx_PH
1週前
Ignoring the Noise: Why MBAK’s Business Execution is the Real Story
It’s honestly exhausting and quite sad to witness. It’s hard not to imagine someone hunched over a keyboard for hours on end, obsessively typing away and digging through legal dockets for who knows who and for what reason—a pursuit that seems to offer no real reward. Anyone who has spent any real time watching the markets knows that these kinds of lawsuits are incredibly common, and more often than not, they end up being dismissed, settled for pennies, or dragged out until they lose all relevance. Getting bogged down in the minute details of "service status" or "default judgments" as if they are some kind of death knell for a company is just noise—it’s legal theatrics, not business analysis.
This noise is often amplified by a single, persistent voice attempting to cast doubt by obsessively framing procedural hurdles as catastrophic events, or by pushing groundless speculation about the "Expert Market" to incite fear. We’ve even seen some recent back-and-forth on the board where this same narrative attempted to over-analyze the contractual relationships involved in the case, only to overlook the actual scope and nature of the claims being made. In my experience, these distractions are designed to obscure the bigger picture. When you look at the company’s certified financial report and the concrete evidence presented during the recent earnings calls, the trajectory for success becomes clear. The company is actively executing on its business plan, and these operational milestones—not the theatrics of online critics—provide the true indicator of the future.
While some are busy playing amateur detective, the company is actually out there executing on real work. That’s where the value is created, not in the courtroom.
Let’s look at the actual facts:
• Share Structure Discipline: The company continues to maintain a stable share count with no toxic dilution. The recent ~25 million share issuance appears aimed at aligning high-caliber talent with the board and organization.
• Financial Momentum: Strong revenue growth continued into Q1 2026 with $3.01 million reported and $1.40 million in net income, reflecting solid gross margins around 51%.
• Operational Progress: The company has produced and positioned BESS units for delivery to India and Africa (with over 55 MWh of capacity referenced in updates). They continue to target substantial additional capacity (including the expanded India contract) through 2026, with the new MBAK India subsidiary supporting fulfillment of the overall $65 million backlog alongside Zambia partnerships.
• Global Expansion: MBAK has incorporated a new subsidiary, MBAK India Private Ltd., to streamline BESS integration for its $65 million order fulfillment, while also securing new partnerships for renewable power projects in Zambia’s Copperbelt.
• Share Repurchase Program: In a move demonstrating confidence in the company's valuation, the Board of Directors has authorized a $500,000 share repurchase plan under SEC Rule 10b-18, funded directly from cash reserves and recent order fulfillment payments.
• Facility Expansion: Plans are in place to move into a 40,000 sq. ft. U.S. manufacturing facility in Wilmington, NC by September 2026.
• Recurring Revenue Floor: Earnings call highlighted a new specialized cell order delivering approximately $750,000 per month for one year, expected to help cover corporate overhead.
Market Outlook:
Beyond the immediate noise, I am looking at the broader picture. The overall market is setting up for a significant run based on the technical charts. This shift is likely to catch many off guard, especially as the current environment starts to feel bleak and discouraging to the average observer. However, this is precisely the type of sentiment that historically signals a prime buying opportunity for those who can see past the temporary gloom.
I’m more interested in the actual business operations and the long-term growth trajectory than I am in following every repetitive update on a lawsuit that is likely to go nowhere. Genuine progress is what moves the needle, and that is exactly what the company is delivering. With experienced leadership and clear delivery milestones, the upside potential is significant. My focus remains on my established price targets, because that is where the fundamental value of the company’s real-world progress will eventually be reflected.
OTC_Watchdog
1週前
@Karmine — you've done more research than most people on this board and you're asking the right questions. But I'd push back on one underlying assumption running through your post: that the $65M order book, the India deliveries, and the tariff explanation are real because MBAK said so.
What is the actual evidence that the $65M order book exists? A press release. What is the evidence that deliveries happened? Another press release. On the May 18 earnings call Boos confirmed the Indian customer had not paid and the certification lab required for delivery did not exist.
Meanwhile MBAK's own certified financial filings show a company that reported $3,010,062 in revenue in Q1 2026 and received zero dollars from customers in the same period. That's not an outside critic's interpretation — it's the arithmetic of their own cash flow statement, certified under penalty of law.
On the reverse split and stock loan — neither was ever a realistic option at this share price and market cap. Their absence proves nothing.
The gap here is not between optimists and pessimists. It's between what Boos says publicly and what Boos certifies in writing. At what point do those contradictions become too big to ignore?
Karmine
1週前
Definitely some unanswered questions here. I find it commendable that Boos did not try an RS or some type of equity loan or draw after the shell was purchased. The staff, the investment, the procurement, and all the OTC red tape and PR has been funded though revenue or out of BOD and or Boos pockets. In addition, if the high tariff structure on Chinese goods sold to India was not fully anticipated, it could have left MBAK cash strapped. $65 million order could lead to north of $10M in tariffs alone. Tough to generate money to the bottom line when 8 figures gets skimmed off the top. I would assume that this may be why there are challenges when it comes to asset allocation. I have some acquaintances that do trade in India and they are know for being slow payers. Hence why Arnold only inventories and sells one rug at a time. If this $65M deal has terms linked to it, it could mean that there is payment lag. Something that even Guido and Nunzio couldn't help with. The obvious conclusion is that cash demands exceed current supply (which happens all the time with rapidly growing businesses) or it's been difficult to find the right attorney to client relationship (remember they are in Asia, not OKC). Lets hope the judge is very compassionate and understanding and gives them more time to mount their own offensive. I have lots of shares here and I am rooting for the home team.
OTC_Watchdog
1週前
@Karmine — fair reading, and you're right that the Master Agreement is between the plaintiffs and MIA Global, not MBAK directly.
The connection to MBAK runs through the RICO claim, not the contract. Under civil RICO, all members of an alleged enterprise are jointly liable — the contract establishes the underlying fraud, and the enterprise allegations in the Amended Complaint name MIA Global, MIA USA, and MBAK as the corporate vehicles through which the scheme operated. Paragraph 109 states the three corporate entities "have no meaningful separation from the individual defendants." That's the alter ego theory — the corporate boundaries don't shield MBAK if the court finds they were operated as a single enterprise.
On "told" not being a contract — correct, which is why the securities fraud counts exist alongside the contract claim. The ALYI shares offered to Long and Anton as inducement are the basis for Counts 7 and 8 (Federal Securities Fraud and State Law Securities Fraud), independent of any written agreement.
On the strength of the case — consider this: if the plaintiffs' case is as weak as it appears to you, the defendants have every incentive to retain counsel and win quickly. A weak case is easy to defeat with competent representation. Instead the corporate defendants are heading toward automatic default, which carries the same legal consequences as losing at trial. A defendant who believes they are in the right and has the means to prove it does not allow that to happen.
The question of why they are not defending themselves is more important than the question of whether the case is strong or weak.
OTC_Watchdog
1週前
@Karmine — the contractual relationship is documented in the court record. Here are the key public filings:
1. The Master Distribution Agreement — the contract between the plaintiff and MIA Global Inc., signed by Michelle Boos as Founder and Chairman. Dated February 10, 2025.
https://archive.org/details/mia-global-master-distribution-agreement-jimmy-long-michelle-boos-2025
2. The Amended Complaint — explains how MBAK connects to MIA Global and the plaintiffs. Paragraph 55 states Boos told the plaintiffs she was acquiring ALYI and converting it to the symbol MBAK. The corporate veil and enterprise allegations name MIA Global, MIA USA, and MBAK together explicitly.
https://archive.org/details/michelle-boos-gabriel-carrelo-mbak-mia-global-federal-amended-complaint-26-cv-00091-sh
3. Plaintiffs' Response to Carrelo's Motion to Dismiss — introduces Gabriel Carrelo, Boos's son, as the "financial architect, or in layman's terms, the Bagman" of the enterprise. Includes a photo from May 2, 2025 showing Carrelo, Boos, and the plaintiffs at a meeting to discuss a fleet of golf carts that, per the filing, would never materialize.
https://archive.org/details/michelle-boos-mbak-mia-global-rico-lawsuit-response-to-dismissal
All three are public court documents from Case No. 4:26-cv-00091-SH, N.D. Oklahoma.
OTC_Watchdog
1週前
Update — Case No. 26-cv-00091-SH, N.D. Oklahoma — filed June 9, 2026
Plaintiff's counsel filed his court-ordered response on service status yesterday.
The filing makes a significant legal argument: Michelle Boos and Nolin Han's own court submissions from May 26 — filed on behalf of the corporate defendants — establish that both individuals had actual notice of this lawsuit. They attempted to buy time with those ffilings. Plaintiff's counsel is now using them as evidence that Boos and Han knew about the case all along.
Those May 26 filings have separately been challenged as procedurally defective. Under 10th Circuit precedent, corporations cannot represent themselves in federal court. Boos and Han filed on behalf of corporate entities without being licensed attorneys. Plaintiff's counsel has moved to strike both filings and requested entry of default against the corporate defendants.
MBAK Energy Solutions and MIA Global were served May 4, 2026. Their deadlines to respond through licensed counsel have passed. No attorney has entered an appearance for any of these corporate entities.
The next procedural step is entry of default by the court clerk, followed by a motion for default judgment. At that point the corporate defendants — including MBAK Energy Solutions — lose the case without a trial.
Two questions worth asking:
Why do MBAK, MIA Global, and their owners continue without legal representation more than four months after this lawsuit was filed?
Why are they allowing the case to proceed toward automatic default rather than retaining counsel to defend it?
The logical answers are only two:
They cannot afford legal representation, or the facts of the case leave them with no viable defense.
Neither reflects well on MBAK or its owners — regardless of what the bulls on this board continue to repeat.
Dnx_PH
1週前
The Strategic Reset: MBAK’s Emergence from the De-risking Era
The “de-risking” era of 2024 was a harsh, systemic filter that forced the entire OTC landscape to recalibrate under the pressure of high interest rates and global economic uncertainty. For many, that period was an anchor—a heavy, dragging force that kept companies pinned down, preventing them from gaining traction and forcing them to survive in a hostile environment where growth was nearly impossible. For MBAK, that period served as a necessary catalyst—a refining process that allowed the company to establish its foundation and focus on its long-term objectives.
During that time, the market was flooded with hollow, speculative narratives that lacked any operational backbone. Because MBAK underwent a structured entry into the public market, much of the internal repositioning happened quietly. That breathing room allowed the company to clear the decks and focus exclusively on the critical infrastructure required for the modern energy transition, particularly within the Battery Energy Storage System (BESS) sector.
We are now officially emerging from that cycle, and the shift feels very real. The austerity of 2024 acted as a brutal training ground that purged the weak and left the survivors stronger and more focused. MBAK has navigated this transition beautifully and is coming out the other side with clear momentum and a sharp focus aligned with global demand.
Most importantly, the company is demonstrating genuine real-world progress. Revenue streams are coming online, the business is moving steadily toward self-sustainability, and management has adopted a refreshingly shareholder-focused approach. By prioritizing transparency and direct engagement—most notably through open video earnings calls that invite public scrutiny—the company has built a layer of institutional credibility that sets it apart from its peers. While broader market sentiment is only beginning to catch on, we are watching a company transform in real time with strong upside potential.
Geopolitical and economic headwinds are easing. High interest rates that crushed small-cap growth are starting to loosen their grip, and instability in energy supply chains is beginning to stabilize. MBAK is now perfectly positioned to benefit from this improving environment.
We have officially moved past the era of hollow narratives. We are now firmly in the era of execution. The pressure that built up during that long, quiet transition is finally being released, and the move ahead has the potential to be very significant for those who stayed patient. The economic “headwinds” that kept the price pinned down are finally dying down, and the spring that has been coiled tight for two years is ready to snap open. Simply put, the company is done with the “growing pains” of its transition and is finally entering the stage where its actual work will speak for itself.
The foundation is solid, the work is getting done, and it’s finally starting to show. We aren’t just looking at the theory anymore—we’re watching the company prove what it can actually do.
Dnx_PH
1週前
The current price action for MBAK is clearly a function of market sentiment failing to align with the company's verified operational progress. This creates a distinct window where fundamental value is being ignored by broader market trends, resulting in a period of intense price compression. This state of inefficiency is a transient phenomenon that simply cannot last forever; price discovery historically aligns with industrial progress the moment the broader market finally incorporates the available facts into its evaluation.
When that transition occurs, the correction tends to be rapid and significant. It is a classic setup where those who have paid attention to the underlying fundamentals will be positioned to witness the market catch up to reality. The current levels are effectively a temporary anomaly, and once the momentum swings to properly reflect the company's output, the opportunity to observe this growth from current pricing will likely be gone. We are at a point where the disconnect between sentiment and performance is stretched to its limit, and the inevitable return to fair valuation appears to be drawing much closer. Everyone watching the sector knows how quickly these windows can close once the market realizes the true value being overlooked.
For those who have read this far, let me put this in plain English: the stock is currently acting like a coiled spring held down by nothing more than a deep, mid-afternoon nap. The company is doing the heavy lifting, but the market is still fast asleep at the wheel. Eventually, the market is going to have its morning coffee, realize what it’s been missing, and send this thing moving. Those who have been paying attention are just sitting back watching the show, knowing that when the rest of the crowd finally wakes up, it’s going to be a mad scramble to catch up. Sleeping on an opportunity like this is a dangerous game—so you better wake up, because when this finally takes off, those who snoozed are going to find that the train has already left the station. Don't be surprised when the current "boring" price becomes a distant memory overnight.
Dnx_PH
2週前
Certified Filings vs. Administrative Snapshots: Focusing on Real Business Value
The argument that a state filing history—which is not the annual report itself—represents an exhaustive, real-time roster of a company's leadership is a fundamental misunderstanding of corporate governance. State administrative documents are periodic snapshots with specific requirements; they are not required to reflect every current team member or update instantaneously. Attempting to conflate these periodic administrative disclosures with an organization's actual human capital is a transparently flawed tactic, especially when there is documented, public-facing evidence of contributions from key leaders like Dr. Konda.
This is why the certified Q1 financial disclosure, signed by Nolin Han under penalty of law on May 14, 2026, remains the more relevant document for assessing the company’s current operational status. It shows tangible assets, revenue, and inventory that reflect actual business activity. Focusing on timing gaps in a state form while ignoring the certified financials and ongoing contract execution misses the bigger picture.
This reliance on pedantic, narrow-scope arguments serves only one purpose: to distract from the value being created. While some prefer to circle the drain of semantics to craft legal scandals where none exist, those focused on the business will continue to look at the contracts, the production pipelines, and the boots-on-the-ground execution. Equating the absence of a name on a form with a lack of professional legitimacy—particularly regarding Dr. Konda’s vital importance to this mission—is not just wrong; it is an act of willful blindness designed to obstruct the perspective of anyone assessing the company’s genuine industrial progress.
Personal Perspective:
Let me be as clear as possible: in my view, the technical setup is becoming increasingly compressed. A rapid retest and breakout toward $0.03 could serve as the immediate catalyst to flush out remaining resistance. Should that volume hit, MBAK is positioned for a violent upward expansion—a classic squeeze dynamic that could propel price discovery toward the near-term markers of $0.08 to $0.10, with a broader long-term trajectory aiming for levels exceeding $0.25. The confluence of fundamental execution and technical pressure suggests the next major leg up is not a matter of if, but when.
Dnx_PH
2週前
The Industrial Reset: Why MBAK is Positioned to Benefit from the BESS Evolution
The attempt to dredge up two-year-old threads is a predictable tactic designed to conflate disparate market environments. It ignores the reality that the OTC landscape underwent a fundamental reset following the regulatory pressures and the "de-risking" era that defined the 2024 period.
During that time, the confluence of high inflation, surging interest rates, and global trade shifts forced a structural retreat from high-risk speculation. That period of austerity acted as a necessary filter, separating those with hollow narratives or poor execution from entities with genuine industrial utility. We are now emerging from that cycle; global capital is recalibrating, and risk appetite is clearly expanding, favoring entities that possess actual, tangible assets.
MBAK is positioned perfectly for this new chapter. The company is operating in the definitive sector that Chairwoman Boos identified as our "cash cow"—Battery Energy Storage Systems (BESS)—which represents the critical infrastructure required for the current energy transition. MBAK is executing on high-value contracts and driving revenue in a sector that is increasingly becoming the bedrock of industrial utility. Chairwoman Boos clearly understands the gravity of this shift; she is positioning the company to capitalize on the acute, systemic need for these essential energy storage systems, while looking toward future opportunities in sectors like electric vehicles.
The current narrative on the board seems to be shifting to a script designed to divert attention toward personal, character-based distraction. I am not interested in that script. My focus remains fixed on the long-term value drivers that are independent of where anyone stood on a ticker two years ago. I have the utmost conviction in the position, and looking at the chart, the tight coiling suggests a significant breakout is imminent. As the broader market matures and the geopolitical pressures that have suppressed energy-sector valuations begin to resolve, this asset is primed for a massive expansion. I will keep my gaze firmly upon the fundamentals, while these faux critics continue to circle the drain of irrelevance, willfully blind to the magnitude of the move that is coming.
Reference:
Michelle Boos interview on BESS
This video provides direct insight into Michelle Boos's strategic vision for MBAK's expansion into Battery Energy Storage Solutions and the company's long-term revenue model.
OTC_Watchdog
2週前
@Karmine — you just listed Dr. Shiva, Louisa Yi, and Song Hoon Kim as key members of MBAK's leadership team.
According to the Wyoming Profit Corporation Annual Report filed June 3, 2026 — signed by Michelle Boos under penalty of perjury — none of the three are directors of this company.
The form requires disclosure of all officers and directors. Boos listed two: herself and Nolin Han.
Dr. Konda was nominated director 140 days before that filing. Kim and Yi were nominated 49 days before. None appear.
If they are not in the government filing, they are not directors. If they are not directors, they are not part of the company's board. So why are they being promoted to investors via press releases and on OTC Markets?
Dnx_PH
2週前
Recent Filing Discussion
The attempt to dissect past commentary on the importance of certified filings is, yet again, a classic diversion. While there is no contradiction in expecting precision in corporate documentation, leveraging a single state-level reporting form as the cornerstone of a “fraud” investigation reflects a fundamental misunderstanding of the distinction between high-level oversight and basic administrative housekeeping.
It is revealing that while substantive work continues—such as the active execution of revenue-generating contracts by operators like Dr. Shiva, who is consistently securing high-value deals and driving real, bottom-line revenue—this ongoing obsession remains centered on winning a message board-level argument over disclosure formatting. If the goal is to play “gotcha” with administrative snapshots, feel free to keep digging. I do not trade in distractions. My focus is fixed on the tangible operational reality and the long-term value drivers that are completely independent of how many names appear on a single, $60 state-level snapshot.
The most critical oversight in this debate is the real-time velocity of capital and contract realization. By tethering their analysis to static, historical snapshots, critics are ignoring the dynamic nature of commercial scaling.
While some search for clerical inconsistencies, they appear blind to:
• Contractual Execution Cycles: The actual transition from signed agreements to revenue-generating deployment.
• Market Penetration Metrics: The speed at which technology is being integrated into operational environments—a far more accurate leading indicator of success than any state-mandated document.
• Strategic Agility: The ability to secure high-value deals in competitive markets, which requires operational focus that is often hindered by excessive administrative scrutiny.
By fixating on the “what” of a filing, these observers are missing the “how” of the business—valuing the packaging over the product itself.
This board can decide whether to track actual industrial deployment or focus on the parsing of clerical records. I will keep my eyes on the assets and the certified progress, while others remain lost in the weeds of trivialities.
The fundamentals remain solid. The transition continues.
OTC_Watchdog
2週前
Update: MBAK has resolved its Wyoming tax delinquency. The company filed its 2026 Profit Corporation Annual Report on June 3 and paid the $60.00 license fee.
Good news — they found $60 in their account.
The filing itself, however, raises a more significant question.
Wyoming's annual report requires disclosure of all officers and directors. Michelle Boos signed this form under the following certification: "I hereby certify under the penalty of perjury that the information I am submitting is true and correct to the best of my knowledge."
The form lists exactly two directors: Michelle Boos and Nolin Han.
Dr. Shiva Konda was announced as a director in a press release on January 14, 2026 — 140 days before this filing. Song Hoon Kim and Shaoyue Yi were announced on April 15, 2026. All three currently appear on MBAK's OTC Markets profile as Independent Directors.
None of the three appear in yesterday's sworn government filing.
Either the press releases and OTC Markets profile announcing these directors are false, or the government filing is false. The Wyoming annual report was signed by Michelle Boos under penalty of perjury.
So which is it? Are Dr. Konda, Song Hoon Kim, and Shaoyue Yi actually serving as directors of this company? And if they are not directors — what exactly is their relationship to MBAK, and why were shareholders told otherwise?
The Wyoming SOS record is public: here
Dnx_PH
2週前
The Industrial Realignment of MBAK
We are witnessing the foundational phase of a significant transition — a company moving from a legacy shell structure into a hard-asset industrial energy storage manufacturer. The market often struggles to price this kind of metamorphosis in real time, but the certified data is beginning to tell a clearer story.
The path forward is anchored in the following verified elements:
• Verified Industrial Assets: Nearly $4M in current assets per the Q1 filing, including $2.09M in physical BESS inventory and $1.79M in receivables. This reflects a tangible shift toward a manufacturing-focused model with real product in the pipeline.
• Leadership and Execution: Nolin Han serves as both CEO and CFO and personally certified the Q1 report under penalty of law. The board also includes directors with technical backgrounds such as Dr. Shiva Konda.
• Capital Discipline: The common share count currently stands at approximately 3,082,453,752, reflecting the recent issuance of ~25 million shares. While the purpose of this issuance is not officially documented, it is common industry practice for such moves to be utilized for team alignment and recruitment rather than toxic dilution. The structure remains stable relative to the total float, and management has indicated active use of the buyback program on dips.
• Revenue Momentum: The company reported $3.01M in Q1 revenue and $1.40M in net income (~51% gross margin). On the earnings call, they highlighted progress toward a $750,000 monthly specialized cell order, which — if sustained — would provide a meaningful revenue floor.
• Forward Milestones: The planned move into a 40,000 sq ft U.S. manufacturing facility in September and continued international deliveries represent visible operational catalysts.
Personal Perspective:
Let me be as clear as possible: in my view, the current market environment is still largely pricing in the legacy shell phase rather than the emerging industrial reality. As production scales and revenue milestones are cleared, it is my personal interpretation that the market will re-rate the stock based on actual revenue velocity. Based on my own reading of the technical patterns, a move toward the 8–10 cent zone appears as a logical near-term possibility, with longer-term potential toward the 25 cent+ range as commercial scale is reached.
The blueprint is in motion. The daily noise is loud precisely because the underlying potential is real. Stay focused on the certified filings and operational progress.
Best regards to all.
Dnx_PH
2週前
Canned Scripts, Glitches, and Broken Math
The sheer desperation on this board has officially crossed into pure comedy. When a critic gets so frantic that they literally blow up my notification inbox with a barrage of rapid-fire public replies in the exact same minute—only to have their duplicate posts immediately vanish or get deleted because they realized they completely embarrassed themselves—you know the reality of these certified fundamentals is causing absolute panic. They are tripping over their own mouse clicks and aggressively spamming alerts just trying to rush out a canned script.
Let's dissect the absolute financial ignorance, broken math, and complete lack of fundamental credibility being masqueraded as a critique:
• The Frantic Inbox Spam: It is hilarious to watch someone panic-click and clutter up a person's mailbox with identical copy-paste text just to demand attention. Accusing others of losing credibility while completely glitching out, spamming alerts, and double-posting under pressure is the ultimate self-own. Watching their messy, repetitive replies get scrubbed or deleted off the board after the fact just proves there is zero real substance here—just a desperate rush to blast a pre-written narrative because the certified numbers are completely bulletproof.
• The Inability to Grasp GAAP and Basic Accounting: It is a running theme with these loud critics that they consistently get fundamental accounting procedures and GAAP math completely wrong. They look at a balance sheet and fundamentally misunderstand how assets, working capital, and revenue velocity interact. They completely choke on the math because they are trying to evaluate a rapidly scaling commercial manufacturer using stagnant shell-company metrics. Any claim to authority they think they have is immediately neutralized by their own public display of financial illiteracy.
• The Broken Forward Valuation Logic: Let’s address how basic micro-cap math actually works. The critic screams about a multi-stage, longer-term fundamental re-rating target of 25 cents as if a forward operational target is supposed to materialize overnight. They look at capital allocation and see a red flag, completely destroying their own analytical reputation by ignoring how forward valuation models work when actual product is moving.
• The Scale Multiplier: The certified Q1 disclosure locked in nearly $4M in current assets ($2.09M physical BESS inventory + $1.79M receivables). A business transitioning into a hard-asset, multi-million-dollar revenue-producing BESS manufacturer does not trade on baseline enterprise multipliers forever. As a global supply chain ramps and massive contracts are fulfilled, forward market valuations re-rate dynamically based on revenue velocity, not ancient history.
The Reality Check:
The contrast is flat-out laughable. On one side, you have an identical, glitched-out script choking on basic math and sweating bullets over a forward-looking target, completely unable to grasp how a commercial manufacturing ramp re-rates a stock chart. On the other side, you have an ironclad, certified Q1 filing signed under penalty of law by Nolin Han, acting in his dual capacity as both Chief Executive Officer and Chief Financial Officer, validating real commercial execution.
An aggressive energy solutions manufacturer doesn't let millions in capital sit dead and idle just to make nervous internet skeptics feel comfortable—they deploy it directly into high-value raw materials, physical inventory, and factory production to fulfill massive contracts. That is textbook execution, and any commentator attempting to spin this aggressive deployment of working capital as a negative completely obliterates their own analytical credibility on this board. Every time they post these desperate, backward logic blocks, they are just exposing their own lack of diligence and ensuring nobody takes their "warnings" seriously.
The chart remains in a tight, coiled consolidation with structurally limited downside at these current levels. Let the background noise spam notifications, double-click their panic scripts, and choke on basic accounting procedures until their posts get deleted again. Once momentum catches fire and the volume engine turns back on, the technical setup is fully primed to snap back. A short-term squeeze easily puts the 8–10 cent zone in play near-term, and as those physical deliveries keep hitting the tape and the factory floor scales, the multi-stage ladder toward a quarter-plus range (25 cents+) is the entirely logical long-term destination.
Keep spamming the reply button and wrecking what little credibility you have left. The certified millions will drive the story.
GLTA!
Dnx_PH
2週前
Observing the Script: Manufactured Drama vs. MBAK’s Operational Reality
Has anyone else noticed the predictable rhythm playing out on the board lately? It feels like we are watching a highly coordinated, two-act performance designed entirely to distract from what actually matters.
Act 1: The Faux Panic
First comes the wave of high-amplitude, alarmist language. You get sudden, manufactured urgency about "imminent" catastrophes and exaggerated worst-case scenarios. It is performative anxiety at its finest, explicitly designed to bypass calm analysis and trigger emotional reactions.
Act 2: The Faux Victory Lap
Right on cue, the exact same circle transitions into a mutual back-slapping routine. There is a lot of vague, high-minded talk about "investigations" and "deep dives" that somehow never produce a single shred of verifiable proof—just more circular noise. It’s a closed loop of self-validation where people high-five each other for solving a crisis they invented.
The Reality Check: Look at the Asset
While this theatrical cycle loops on repeat, the actual thesis for MBAK remains completely intact. Look past the message board theater and focus on the structural evolution: we are watching a company successfully transition from a legacy shell into an active energy storage and manufacturing operation.
The certified Q1 numbers put the reality on paper: millions in revenue, strong gross margins, physical inventory buildup, and real product moving across continents.
That kind of raw, early-stage growth potential—combined with a remarkably tight, flat share structure and upcoming manufacturing milestones—is exactly why the noise gets so loud the moment positive developments appear. Real upside always attracts the loudest distractions.
Don’t let a performative script dictate your strategy. Stay grounded in the certified filings and the company’s actual operational trajectory. The long-term setup here is incredibly compelling for anyone who knows how to read a balance sheet instead of a script.
Fundamentals over noise.
Dnx_PH
2週前
Recent Court and Filing Discussion
The latest wave of panic over procedural court letters, filing status, and anonymous “SEC ghost stories” is reaching comedy-level hysteria.
Yes, corporations in federal court are generally expected to use licensed counsel for formal pleadings. However, twisting a routine initial request for an extension of time into “imminent default judgment” or corporate collapse is pure exaggeration. Courts grant these extensions all the time. This is basic procedural housekeeping, not Armageddon.
The Pink Market vs Expert Market fear-mongering is equally overblown. MBAK is filing quarterly reports (the certified Q1 was submitted on time). Administrative lags during a ticker transition and manufacturing ramp are common in micro-caps. Turning delayed uploads into “they’re getting delisted to the Expert Market any day now” is desperate scare tactics.
While some people are obsessing over state registry upload dates, the executive team is under penalty of law validating millions in physical BESS inventory on the factory floor.
As for the vague “someone close to the SEC Enforcement Department is watching the board” rumors — that’s one of the oldest, most recycled scare tactics in the micro-cap playbook. Real regulatory agencies don’t take enforcement action based on anonymous message board tipsters. It’s empty noise designed to manufacture fear and induce selling.
What actually matters is the certified Q1 disclosure signed by Nolin Han (CEO & CFO) on May 14, 2026 under penalty of law. Those legally binding numbers show:
• $3.01M in Q1 revenue
• $1.40M in net income
• Nearly $4M in current assets, including $2.09M physical BESS inventory and $1.79M receivables
A scaling manufacturer doesn’t hoard idle cash to please skeptics — it deploys capital into real product to fulfill contracts. That’s execution, not a red flag.
The contrast is laughable. The chart is in tight consolidation with structurally limited downside. Once momentum catches fire and volume returns, this could easily rip toward the 8–10 cent zone near-term. If deliveries keep flowing and the factory ramp hits, a multi-stage move back toward the quarter-plus range (25 cents+) becomes very realistic.
Let the noise spin. The actual numbers will drive the story. GLTA!
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
メールアドレスで登録
